New England Compounding Center Indictment
Cabaleiro, J.
International Journal of Pharmaceutical Compounding 19(2): 94-102
2015
ISSN/ISBN: 1092-4221 PMID: 26685489 Document Number: 679970
This article is a review of the lapses in compliance with United States Pharmacopeia standards and pharmacy law as alleged by the New England Compounding Center indictment. This indictment was a result of an outbreak of fungal meningitis traced to fungal contamination of compounded methylprednisolone suspension for epidural steroid injections. This article is also intended as a gap analysis for compounders to review compliance at their own facility, and, if necessary, take the appropriate steps to implement best practices.